Recently, HM Healthcare Management Services’ new business segment “HM Digital” and AI intelligent data analysis platform Stratifyd reached a formal strategic cooperation agreement, the two cooperation will contribute to the pharmaceutical industry a new intelligent digital marketing solution.
>>>>
The demand for patient groups in the current pharmaceutical companies is growing
In recent years, pharmaceutical companies have introduced the concept of “patient-centered” into the market strategy. Especially after the launch of the “New Deal” such as “4+7”, the out-of-hospital market with greater patient discourse has determined the drug companies in the patient group. Give more attention. In addition, as patients become more deeply involved in the choice of treatment methods and the evaluation of treatment outcomes, the voice and power of patients are increasingly affecting the medical industry. For pharmaceutical companies, understanding the patient’s perception of the drug, understanding the reasons related to the patient’s compliance with the drug, and understanding the patient’s needs can provide a great opportunity for the drug company to make new product research and development, drug quality monitoring, drug sales strategy and other decisions. The basis for the value.
Patient group insight research has been relatively mature abroad. Research and service patients are important directions in the market sectors and medical departments of foreign pharmaceutical companies. It is reported that research and services on patient behavior often account for 10-20% of the promotion budget. They are more concerned with analyzing the external voices and behaviors of patients, including analyzing patients’ considerations on drug efficacy, adverse reactions, drug economy, etc., locating patient groups and making patient images to gain insight into the patient’s internal needs. The adjustment of product-related strategies will ultimately serve the patients better, and will improve the efficacy and accessibility, reduce the cost of treatment and improve the treatment experience as the end point.
>>>>
PGI products, to solve the problem of patient group insight
In general, there are usually two market research solutions on the market for patient group insight needs.
The first research solution is to develop a direct understanding of the patient through a large number of patient-based, problem-specific interviews. Or form an indirect understanding of the patient by interviewing a certain number of doctors based on specific questions. Doctors have more patients at work, and they have a general perception of the patient group’s voice. Through doctor-based interviews, patient group images can be quickly obtained.
The second research solution is “Social Listening”, which is to crawl web content with these keywords by setting keywords and using “web crawler” techniques, and then manually processing, such as crawling content. Finishing, refining medical content, making various charts and PPTs for conclusions, and finally forming deliverables.
PGI (Patient Group Insight System) is a patient listening and insight product developed by HM Digital and AI data analysis platform manufacturer Stratifyd to help pharmaceutical companies accurately understand the characteristics of patient groups. PGI is a method of “Social Listening”, which incorporates artificial intelligence techniques such as natural language understanding (NLP) and knowledge maps to more accurately mine the insights of needs analysis and causality behind the public voice.
For example, the traditional technology to identify the keyword “headache” may create many ambiguities that make it impossible to dig into what the patient really wants to express. PGI can accurately identify the practical meaning of the phrase with the “headache” keyword in the actual context. For example, “I feel a headache after taking the medicine” is to describe the side effects of the patient’s medication. “This medicine can alleviate the headache problem” is Describe the patient’s disease symptoms, “a headache for drug prices” is to describe the drug economy.
HM Digital leverages the strengths of its own medical team and data science team, combined with Stratifyd’s industry-leading experience in natural language processing and automated modeling to contribute to the industry’s fast, flexible and powerful AI data. The analytical platform, the strong combination of the two enables the project to quickly reach the depth of the pharmaceutical industry. Compared with the previous two research methods, PGI can greatly improve automation, reduce manual work, and continuously monitor through the system.
At present, PGI has served a number of Top 20 multinational pharmaceutical companies. For example, PGI built the Engage platform for a mature drug from a large European pharmaceutical company to understand the needs, interests, and problems of kidney transplant patients, and to further understand the needs, interests, problems, etc. of kidney transplant patients. In order to carry out product-related strategic adjustments, it will help to increase market share.
In another example, PGI is a large US-based drug company that understands the long-term survival and out-of-hospital management of patients in the overall diabetes market, as well as the doctor’s awareness of the importance of out-of-hospital management, thereby helping the pharmaceutical market to determine the survival of patients. Focus on achieving long-term monitoring and evaluation of patient education activities.
In addition to the pharmaceutical industry, PGI also contributes to the medical device sector. By providing services to a large US-based medical device company to help them understand the unmet needs and concerns of patients undergoing bypass surgery, the patient’s clinical pathways, key decision points, and hospital physician selection criteria were finally understood and validated.
>>>>
Strong combination to help pharmaceutical companies achieve digital and intelligent marketing decisions
HM Digital is a new business segment of HM Healthcare Management Services, and HM Healthcare, a subsidiary of HM Healthcare Management Services, is integrated into HM Digital. HM Digital is committed to using “digital technology” as the core, based on medical device data, disease information data, doctor portrait data, patient image data, clinical diagnosis and treatment data, etc., based on medical science, marketing science, knowledge map Leading technologies such as artificial intelligence are the main driving force to help medical industry entities realize digitalization and intelligence, and ultimately reduce enterprise costs, enhance user experience, increase industry revenue and upgrade industrial models, and effectively use digital technology to drive medical and health enterprises to achieve innovative intelligence. Development.
HM Digital’s management team members come from IMS (now IQVIA), Veeva, IBM, Accenture, Tencent and many other world-renowned companies. The team members are diverse, from the world’s top prestigious universities and domestic Qingbei, including clinical medicine, pharmacy, Life sciences, computer science, mathematical statistics, business management and other fields, with many years of experience in digital and technological services of pharmaceutical companies, the project types cover the informationization scenarios of various pharmaceutical companies from basic software, business applications, and cutting-edge innovation. HM Digital’s main team includes medical team, development team and data science team. Its core team members have more than 10 years experience in pharmaceutical companies. The service companies cover all top 20 foreign-invested pharmaceutical companies and domestic leading companies. pharmacy company.
Stratifyd is one of only three “Cool Vendors” in Gartner’s 2018 analysis field. Its platform is about the powerful functions of quickly docking external data, automatically training semantic models and forming AI algorithms. It has won many Fortune 500 since its inception. Enterprise’s order, Stratifyd’s most competitive core text analysis function is equipped with NAI, NLU, orientation monitoring model and other AI underlying technologies, which can help enterprises effectively mine all-channel user feedback data information, so that enterprises can directly pass through the phenomenon. Understand the reasons behind the problem and understand the emotional attitudes and opinions of the target group.
With its superior algorithms and AI underlying technology, Stratifyd became a solution provider for Lilly’s global data analytics in 2017, and has also been a global pharmaceutical giant represented by GSK, the world’s largest pharmaceutical group. The signing of the enterprise, Stratifyd’s strength background is also an important factor in the successful cooperation between the two companies. In the Stratifyd service process, the ability based on its own platform not only contributed to the precise positioning of important clinical problems of pharmaceutical products for the first-line pharmaceutical giants. It also integrates and analyzes patient feedback data for new drug research and development, and successfully makes predictions and decision-making references for new drug market launches, greatly improving the efficiency of drug market research and effectively assisting pharmaceutical companies to achieve performance improvement. Stratifyd The cooperation with HM Micro is based on the shared values and industry value-driven philosophy. It is hoped that the application of the experience will be more widely applied and driven in the pharmaceutical industry.
HM Digital and Stratifyd adhere to the common concept of data-driven industry transformation. I believe that the future medical field must be a new business model of data and AI as the infrastructure. The strategic cooperation between the two is even more powerful for this trend. Accelerate effective trials with a collection of advanced experiences. In the near future, HM Digital will work with Stratifyd to contribute to the industry’s intelligent medical solutions for a variety of different scenarios, helping the pharmaceutical industry’s intelligent trend to go smoothly.
>>>>
About HM
HM Digital is a new business segment of HM Healthcare Management Services, and the HM YIJIAN business of the former HM Healthcare Management Services is integrated into HM Digital. HM Healthcare Management Services is a medical group company co-invested in 2015 by Hillhouse Capital, an investment company that specializes in long-term structured value investments, and Mayo Clinic, a well-known non-profit medical institution in the United States.